Pricing Log in Create free account

Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs BioAtla, Inc. (BCAB)

Addex Therapeutics Ltd. Sponsored ADR and BioAtla, Inc. are both Biotechnology companies. Addex Therapeutics Ltd. Sponsored ADR and BioAtla, Inc. are of similar size ($3.1M and $2.9M). BioAtla, Inc. grew revenue faster over the last twelve months: 574.7% against −75.8%. Addex Therapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −177.2%) and the lower return on invested capital (−141.2% vs 0.00%). Across the 16 metrics below, BioAtla, Inc. leads on 9 and Addex Therapeutics Ltd. Sponsored ADR on 7.

Valuation

Metric ADXN BCAB Biotechnology median
P/E n/m n/m 10.60
P/S 12.90 0.19 9.40
P/B 1.23 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.67 0.69 9.02
Earnings yield (302.94%) (1,272.50%) (32.88%)
Free cash flow yield (99.60%) (709.98%) (23.13%)

Profitability

Metric ADXN BCAB Biotechnology median
Gross margin 43.88% 95.44% 68.51%
Operating margin 0.00% (180.99%) 0.00%
Net margin 0.00% (177.21%) 0.00%
Free cash flow margin 0.00% (132.29%) 0.00%
Return on equity (154.91%) 118.74% (51.96%)
Return on assets (117.46%) (171.72%) (46.06%)
Return on invested capital (141.24%) 0.00% 0.00%

Growth

Metric ADXN BCAB Biotechnology median
Revenue growth (TTM) (75.77%) 574.65% 6.76%
EPS growth (last fiscal year) (191.09%) 29.86% 29.88%
Revenue growth, 5-year CAGR (60.68%) (28.40%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN BCAB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 0.20 4.97
Net debt to EBITDA 0.58 0.12 1.01

Dividend

Metric ADXN BCAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADXN BCAB Biotechnology median
Market cap 3.07m 2.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack